Disease | progressive multifocal leukoencephalopathy |
Phenotype | C0751967|relapsing-remitting multiple sclerosis |
Sentences | 1 |
PubMedID- 20442571 | Recent findings: natalizumab, a mab targeting the alpha-4 integrins, which is efficient in relapsing-remitting multiple sclerosis, has been associated with progressive multifocal leukoencephalopathy (pml). |
Page: 1